Kringle Pharma, Inc. (TYO:4884)
Japan flag Japan · Delayed Price · Currency is JPY
510.00
-64.00 (-11.15%)
Nov 18, 2026, 10:50 AM JST

Kringle Pharma Statistics

Total Valuation

Kringle Pharma has a market cap or net worth of JPY 4.28 billion. The enterprise value is 2.59 billion.

Market Cap4.28B
Enterprise Value 2.59B

Important Dates

The last earnings date was Wednesday, November 11, 2026.

Earnings Date Nov 11, 2026
Ex-Dividend Date n/a

Share Statistics

Kringle Pharma has 8.38 million shares outstanding. The number of shares has increased by 12.92% in one year.

Current Share Class 8.38M
Shares Outstanding 8.38M
Shares Change (YoY) +12.92%
Shares Change (QoQ) +6.25%
Owned by Insiders (%) 6.32%
Owned by Institutions (%) 5.27%
Float 6.95M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 10.89
PB Ratio 4.13
P/TBV Ratio 4.13
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 7.08
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 10.77, with zero debt.

Current Ratio 10.77
Quick Ratio 9.62
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -65.72% and return on invested capital (ROIC) is -41.13%.

Return on Equity (ROE) -65.72%
Return on Assets (ROA) -25.09%
Return on Invested Capital (ROIC) -41.13%
Return on Capital Employed (ROCE) -45.30%
Weighted Average Cost of Capital (WACC) 6.14%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count17
Asset Turnover 0.22
Inventory Turnover 0.33

Taxes

In the past 12 months, Kringle Pharma has paid 1.00 million in taxes.

Income Tax 1.00M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +22.61% in the last 52 weeks. The beta is 0.34, so Kringle Pharma's price volatility has been lower than the market average.

Beta (5Y) 0.34
52-Week Price Change +22.61%
50-Day Moving Average 531.44
200-Day Moving Average 426.28
Relative Strength Index (RSI) 47.26
Average Volume (20 Days) 309,730

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Kringle Pharma had revenue of JPY 442.00 million and -813.00 million in losses. Loss per share was -105.23.

Revenue442.00M
Gross Profit 371.00M
Operating Income -814.00M
Pretax Income -812.00M
Net Income -813.00M
EBITDA n/a
EBIT -814.00M
Loss Per Share -105.23
Full Income Statement

Balance Sheet

The company has 1.68 billion in cash and no debt, with a net cash position of 1.68 billion or 200.52 per share.

Cash & Cash Equivalents 1.68B
Total Debt n/a
Net Cash 1.68B
Net Cash Per Share 200.52
Equity (Book Value) 1.17B
Book Value Per Share 137.80
Working Capital 1.76B
Full Balance Sheet

Cash Flow

Operating Cash Flow -563.00M
Capital Expenditures n/a
Depreciation & Amortization n/a
Net Borrowing n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 83.94%, with operating and profit margins of -184.16% and -183.94%.

Gross Margin 83.94%
Operating Margin -184.16%
Pretax Margin -183.71%
Profit Margin -183.94%
EBITDA Margin n/a
EBIT Margin -184.16%
FCF Margin n/a

Dividends & Yields

Kringle Pharma does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -12.92%
Shareholder Yield -12.92%
Earnings Yield -20.63%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Kringle Pharma has an Altman Z-Score of 1.62 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.62
Piotroski F-Score 2